Loyal, a first-of-its-kind anti-aging drug, enters U.S. clinical trial for senior dogs.

A pioneering anti-aging drug called Loyal has reached an important milestone, as senior dogs in the U.S. are now participating in a clinical trial by taking the pill. The drug is designed to extend the life of dogs and is the first of its kind.

February 17, 2024
4 Articles

Further Reading